Assenagon Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Assenagon Asset Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-462,867	Closed	-$1.94M	–	1458
2022 Q4	$1.94M	Hold	462,867	–	–	0.01%	824
2022 Q3	$1.86M	Hold	462,867	–	–	0.01%	739
2022 Q2	$5.23M	Sell	462,867 -284,260	-38%	-$3.41M	0.02%	531
2022 Q1	$12.1M	Buy	747,127 +405,497	+119%	+$10.4M	0.03%	320
2021 Q4	$16.2M	Buy	341,630 +161,131	+89%	+$9.67M	0.05%	234
2021 Q3	$13.1M	Buy	180,499 +97,109	+116%	+$7.02M	0.04%	256
2021 Q2	$7M	Buy	+83,390	New	+$5.5M	0.02%	410

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Assenagon Asset Management's NBP Position: Q1 2023 in Review

Assenagon Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2023, closing a stake of 462,867 shares — an estimated $1.94M sold.

Assenagon Asset Management first reported a position in NBP in Q2 2021 and held it in 7 quarters. The position peaked at $16.2M in Q4 2021. 53 funds tracked by Wall St. Rank hold NBP as of Q1 2023.

Assenagon Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Assenagon Asset Management sold 462,867 NovaBridge Biosciences American Depositary Shares shares in Q1 2023, an estimated $1.94M.
Assenagon Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 7 quarters.
Assenagon Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $16.2M in Q4 2021.
53 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2023.

Based on Assenagon Asset Management's 13F filing for Q1 2023, filed 18 Apr 2023.